Imitinef Mercilet or Imatinib Mesylate is sold under the brand name Gleevec to treat blood cancer. Imatinib Mesylate is an oral pill given during chemotherapy to target and kill cancer cells that multiply profusely. However, it cannot cure cancer completely.
All cancer cells rest and multiply at different times. The available treatments mostly cannot kill cancer cells that are in the resting phase. It is a possibility that some cancer cells remain in their resting phase during the treatment to become active later on. However, medication these days is trying to target cancer cells in their resting phase to maximize the effectiveness of the medication. Further research is needed to understand the mechanism of these medications against cancer cells in their resting phase.
That being the case, Imatinib Mesylate cannot cure cancer completely. The National Cancer Institute (NCI) website has shown that Imatinib Mesylate is a government-approved drug to treat different types of blood cancer and increase the survival rate. Imatinib Mesylate is a prescription-based drug available all over India and has been in clinical practice for more than a decade now.
There is no medication sold in the Indian market by the name of Imitinef Mercilet.
Disclaimer: Medical Science is an ever evolving field. We strive to keep this page updated. In case you notice any discrepancy in the content, please inform us at [email protected]. You can futher read our Correction Policy here. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website or it's social media channels. Read our Full Disclaimer Here for further information.